These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete. Conant-Norville DO; Tofler IR Clin Sports Med; 2005 Oct; 24(4):829-43, viii. PubMed ID: 16169448 [TBL] [Abstract][Full Text] [Related]
5. The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective. Garner AA; Hansen AA; Baxley C; Ross MJ Sports Med; 2018 Mar; 48(3):507-512. PubMed ID: 29198023 [TBL] [Abstract][Full Text] [Related]
8. Considerations in the Use of Stimulants in Sport. Reardon CL; Factor RM Sports Med; 2016 May; 46(5):611-7. PubMed ID: 26712509 [TBL] [Abstract][Full Text] [Related]
9. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
10. Attention-deficit-hyperactivity disorder: an update. Dopheide JA; Pliszka SR Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419 [TBL] [Abstract][Full Text] [Related]
11. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit]. Bricard C; Boidein F Encephale; 2001; 27(5):435-43. PubMed ID: 11760693 [TBL] [Abstract][Full Text] [Related]
12. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy. Mohammadi M; Akhondzadeh S Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816 [TBL] [Abstract][Full Text] [Related]
13. Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder. Pujalte GGA; Maynard JR; Thurston MJ; Taylor WC; Chauhan M Clin J Sport Med; 2019 May; 29(3):245-256. PubMed ID: 29189334 [TBL] [Abstract][Full Text] [Related]
14. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. Pliszka SR J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053 [TBL] [Abstract][Full Text] [Related]
15. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Pliszka SR Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655 [TBL] [Abstract][Full Text] [Related]
16. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate. Negrao BL; Bipath P; van der Westhuizen D; Viljoen M Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382 [TBL] [Abstract][Full Text] [Related]
18. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy. Tan M; Appleton R Arch Dis Child; 2005 Jan; 90(1):57-9. PubMed ID: 15613514 [TBL] [Abstract][Full Text] [Related]
19. Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement. Putukian M; Kreher JB; Coppel DB; Glazer JL; McKeag DB; White RD Clin J Sport Med; 2011 Sep; 21(5):392-401. PubMed ID: 21892014 [TBL] [Abstract][Full Text] [Related]
20. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]